CD274 and neoplasm: More recently, EZH2 inhibition, by activating the double-stranded RNA-STING stress response, has been shown to increase interferon pathway activity and PD-L1 expression by tumour cells, suggesting that the combination of HMTs inhibitors with immune checkpoint inhibitors could improve the therapeutic outcome [71].